Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Date:7/29/2009

ility of revenue mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; timely and successful consummation and implementation of strategic initiatives; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the uncertainty associated with the identification and successful consummation of external business development transactions; market acceptance of and continued demand for Watson's products; costs and efforts to defend or enforce intellectual property rights; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; uncertainties related to the timing and outcome of litigation and other claims; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Annual Report on Form 10-K for the year ended December 31, 2008. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

Adderall XR(R) is a registered trademark of Shire, LLC.

The following table presents Watson's results of operations for the three and six months ended June 30, 2009 and 200
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 28, 2015 How best to treat ... field in orthopaedic medicine. While diagnostic hip injections are ... the pain etiology, research presented today at the American ... Day suggests that pain relief from this diagnostic injection ... , “Our study looked to assess if the ...
(Date:3/28/2015)... Lately the student-athlete experience has undergone ... around the NCAA. In a March episode of ... a spectrum of universities and sports shed light on ... panel consists of athletes who have competed for universities ... and field, baseball, and volleyball. They discuss the value ...
(Date:3/28/2015)... Virginia (PRWEB) March 28, 2015 ARDX will ... 28th from 12pm -3pm at the Chesapeake Conference Center in ... by sponsoring an empowering event for women in the Hampton ... Weaving the Stories of Women’s Lives. Women grow stronger ... from each other. This year the WWC™ theme is ...
(Date:3/27/2015)... Long Island, NY (PRWEB) March 27, 2015 ... objective, cancer-focused training and business criteria for the spa ... and services to clients who have experienced or are ... of the global Spafinder Wellness 365® Network, will be ... Spafinder.com and recognized as a provider of safe, therapeutic ...
(Date:3/27/2015)... Kansas City, Mo (PRWEB) March 27, 2015 ... common complications for patients undergoing percutaneous coronary intervention ... Ironically, studies have observed a “risk-treatment paradox,” in ... to gain from treatment are treated less often ... , Researchers at Saint Luke’s Mid America Heart ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3
... By Serena Gordon HealthDay Reporter , THURSDAY, ... four new studies suggest that you could benefit from longer ... done at home or at a dialysis center, but it ... rates and improve quality of life, according to the research ...
... Voluminous research literature attests to the multiple negative ... health and development of children. In contrast, there is ... fathers according to a follow up study by NYU ... edition of Maternal and Child Health Journal. ...
... Doheny HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay ... reduce stroke risk, new research suggests. Diets rich in ... in other studies, but researchers weren,t sure why. For this ... citrus fruits and found a winner. "These data provide ...
... Dotinga HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay ... of those known to be infected, actually struck many more ... analysis finds. The actual fatality rate of the H5N1 ... that millions of people may have been infected over the ...
... B, AB or O. You may even know if you,re ... type? Or the Junior blood type? Positive or negative? Most ... knowledge could be "a matter of life and death," says ... problems due to Langereis and Junior blood types are rare ...
... , THURSDAY, Feb. 23 (HealthDay News) -- ... and emergency department visits, improved patient outcomes and saved ... study. Researchers examined the impact of the Community ... families, developed and implemented in 2005 by a team ...
Cached Medicine News:Health News:More Kidney Dialysis Is Better, Research Finds 2Health News:More Kidney Dialysis Is Better, Research Finds 3Health News:Characteristics of fathers with depressive symptoms 2Health News:Characteristics of fathers with depressive symptoms 3Health News:Citrus Fruits May Lower Women's Stroke Risk 2Health News:Citrus Fruits May Lower Women's Stroke Risk 3Health News:'Bird' Flu May Be More Common in Humans, But Less Deadly 2Health News:Blood mystery solved 2Health News:Blood mystery solved 3Health News:Home-Visit Program May Improve Child's Asthma 2
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, Inc. ... medical device company focused on oncology with an ... liver cancers, announces the reporting of data from ... Hydrochloride for Injection with the Delcath Hepatic Delivery ... presentation at the Society of Surgical Oncology (SSO) ...
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
(Date:3/26/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... on Omega-3 therapies for cardiovascular disease and overall health, ... common shares of the Corporation (the "Common Shares"). The ... of December 5 th , 2014 to March 4 ... is due on or before April 1, 2015. Interest ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... Oct. 27 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... and $126.4 million for the second quarter and first ... million and $230.5 million, respectively, during the corresponding periods ... lower for the second quarter and first six months ...
... 27 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... financial results before the market opens on Tuesday, November 10, ... be held on Tuesday, November 10, 2009 at 10:00 a.m. ... the call, please dial 888-417-8462 (for U.S. callers) or 719-457-2552 ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 7Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009 2
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... Services is a Web-based and RFID-enabled location ... and measure patient flow and utilization of ... to discharge. AgileTrac collects patient information including ... your patient might experience. This information is ...
... To the network of door controllers, ... regular intervals throughout the coverage area. These ... Pulsing tags. Although similar in size and ... tag used with RoamAlert ECO and RoamAlert ...
... positioning solution (IPS) enables ... and when equipment, staff ... care processes. This time-stamped ... that hospitals can use ...
Medicine Products: